Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06458296
Status:
COMPLETED
Last Update Posted:
2024-06-13
First Post:
2024-06-04
Brief Title:
Evaluating the Efficacy of AI-Guided GenAIS TM vs Standard Physician-Guided Dietary Supplement Prescriptions for Weight Loss in Obese Patients
Sponsor:
SLAB SOLOWAYS
Organization:
SLAB SOLOWAYS
Study Overview
Official Title:
Evaluating the Efficacy of AI-Guided vs Standard Physician-Guided Dietary Supplement Prescriptions for Weight Loss in Obese Patients A Randomized Controlled Pilot Trial
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Obesity a chronic disease characterized by excessive fat accumulation significantly impacts health Genetic factors influence the development of obesity by affecting behavioral dietary habits and metabolic processes This study investigated whether dietary supplements DS personalized through genetic and metabolic profiling could enhance weight loss when combined with physical activity and dietary changes The objective was to compare the efficacy of standard physician-guided DS prescriptions with AI-guided DS prescriptions in promoting weight loss in obese patients The hypothesis was that AI-guided DS prescriptions utilizing detailed genetic and metabolic data would be more effective in promoting weight loss than standard physician-guided DS prescriptions This was a 6-month randomized controlled pilot clinical trial with an additional 6-month follow-up Participants were healthy individuals aged 40-60 years with a BMI of 25 or greater Participants were excluded if they had significant medical conditions or recent changes in medication or supplements They were randomly assigned to either the control group physician-guided DS prescriptions or the AI-guided group AI-determined DS prescriptions The AI system developed by Triangel Scientific analyzed genetic metabolic and biochemical data to personalize treatment Baseline measurements included comprehensive metabolic panels genetic testing metabolomic profiling and detailed patient history
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None